We serve Chemical Name:(4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid CAS:1003298-85-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid
CAS.NO:1003298-85-8
Synonyms:(3,5-dichloro-4-phenylmethoxyphenyl)boronic acid
Molecular Formula:C13H11BCl2O3
Molecular Weight:296.94200
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.69000
Exact Mass:296.01800
LogP:2.25220
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (3,5-dichloro-4-phenylmethoxyphenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3,5-dichloro-4-phenylmethoxyphenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3,5-dichloro-4-phenylmethoxyphenyl)boronic acid Use and application,(3,5-dichloro-4-phenylmethoxyphenyl)boronic acid technical grade,usp/ep/jp grade.
Related News: If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said. (4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid manufacturer Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. (4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid supplier Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. (4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid vendor On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. (4-(Benzyloxy)-3,5-dichlorophenyl)boronic acid factory Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions.
